Selected research
Industry Growth & Trends
Global Dry Age-Related Macular Degeneration Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Dry Age-Related Macular Degeneration market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dry Age-Related Macular Degeneration is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dry Age-Related Macular Degeneration is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dry Age-Related Macular Degeneration is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Dry Age-Related Macular Degeneration market include Santen Pharmaceuticals, Y2 Solution, Stealth Biotherapeutics, Phio Pharmaceuticals, Ocumension Therapeutics, Kubota Vision, Iveric Bio, Eyestem Research and Belite Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dry Age-Related Macular Degeneration market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dry Age-Related Macular Degeneration market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dry Age-Related Macular Degeneration market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dry Age-Related Macular Degeneration.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Dry Age-Related Macular Degeneration market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dry Age-Related Macular Degeneration Market by Company
Santen Pharmaceuticals
Y2 Solution
Stealth Biotherapeutics
Phio Pharmaceuticals
Ocumension Therapeutics
Kubota Vision
Iveric Bio
Eyestem Research
Belite Bio
Bausch Health
Allergan
Alimera Science
Dry Age-Related Macular Degeneration Segment by Type
Oral
Injectables
Dry Age-Related Macular Degeneration Segment by Application
Above 40 Years
Above 60 Years
Above 75 Years
Dry Age-Related Macular Degeneration Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Age-Related Macular Degeneration market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Age-Related Macular Degeneration and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Age-Related Macular Degeneration.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dry Age-Related Macular Degeneration companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injectables
Applications
- Above 40 Years
- Above 60 Years
- Above 75 Years
Companies covered
- Santen Pharmaceuticals
- Y2 Solution
- Stealth Biotherapeutics
- Phio Pharmaceuticals
- Ocumension Therapeutics
- Kubota Vision
- Iveric Bio
- Eyestem Research
- Belite Bio
- Bausch Health
- Allergan
- Alimera Science
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Dry Age-Related Macular Degeneration Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Dry Age-Related Macular Degeneration Market Size by Region (2021-2032)
- 1.4.1 Global Dry Age-Related Macular Degeneration Market Size by Region (2021-2026)
- 1.4.2 Global Dry Age-Related Macular Degeneration Market Size by Region (2027-2032)
- 1.5 Key Regions Dry Age-Related Macular Degeneration Market Size (2021-2032)
- 1.5.1 North America Dry Age-Related Macular Degeneration Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Dry Age-Related Macular Degeneration Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Growth Rate (2021-2032)
- 1.5.4 South America Dry Age-Related Macular Degeneration Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth Rate (2021-2032)
2 Dry Age-Related Macular Degeneration Market by Type
- 2.1 Type Introduction
- 2.1.1 Oral
- 2.1.2 Injectables
- 2.2 Global Dry Age-Related Macular Degeneration Market Size by Type
- 2.2.1 Global Dry Age-Related Macular Degeneration Market Size Overview by Type (2021-2032)
- 2.2.2 Global Dry Age-Related Macular Degeneration Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Dry Age-Related Macular Degeneration Market Size Forecasted by Type (2027-2032)
- 2.3 Global Dry Age-Related Macular Degeneration Market Size by Regions
- 2.3.1 North America Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2021-2026)
3 Dry Age-Related Macular Degeneration Market by Application
- 3.1 Type Introduction
- 3.1.1 Above 40 Years
- 3.1.2 Above 60 Years
- 3.1.3 Above 75 Years
- 3.2 Global Dry Age-Related Macular Degeneration Market Size by Application
- 3.2.1 Global Dry Age-Related Macular Degeneration Market Size Overview by Application (2021-2032)
- 3.2.2 Global Dry Age-Related Macular Degeneration Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Dry Age-Related Macular Degeneration Market Size Forecasted by Application (2027-2032)
- 3.3 Global Dry Age-Related Macular Degeneration Market Size by Regions
- 3.3.1 North America Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Dry Age-Related Macular Degeneration Industry Trends
- 4.2 Dry Age-Related Macular Degeneration Industry Drivers
- 4.3 Dry Age-Related Macular Degeneration Industry Opportunities and Challenges
- 4.4 Dry Age-Related Macular Degeneration Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Dry Age-Related Macular Degeneration Revenue (2021-2026)
- 5.2 Global Dry Age-Related Macular Degeneration Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Dry Age-Related Macular Degeneration Key Company Headquarters & Area Served
- 5.4 Global Dry Age-Related Macular Degeneration Company, Product Type & Application
- 5.5 Global Dry Age-Related Macular Degeneration Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Dry Age-Related Macular Degeneration Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Dry Age-Related Macular Degeneration Players Market Share by Revenue in 2025
- 5.6.3 2025 Dry Age-Related Macular Degeneration Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Santen Pharmaceuticals
- 6.1.1 Santen Pharmaceuticals Company Information
- 6.1.2 Santen Pharmaceuticals Business Overview
- 6.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Portfolio
- 6.1.5 Santen Pharmaceuticals Recent Developments
- 6.2 Y2 Solution
- 6.2.1 Y2 Solution Company Information
- 6.2.2 Y2 Solution Business Overview
- 6.2.3 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Y2 Solution Dry Age-Related Macular Degeneration Product Portfolio
- 6.2.5 Y2 Solution Recent Developments
- 6.3 Stealth Biotherapeutics
- 6.3.1 Stealth Biotherapeutics Company Information
- 6.3.2 Stealth Biotherapeutics Business Overview
- 6.3.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Portfolio
- 6.3.5 Stealth Biotherapeutics Recent Developments
- 6.4 Phio Pharmaceuticals
- 6.4.1 Phio Pharmaceuticals Company Information
- 6.4.2 Phio Pharmaceuticals Business Overview
- 6.4.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Portfolio
- 6.4.5 Phio Pharmaceuticals Recent Developments
- 6.5 Ocumension Therapeutics
- 6.5.1 Ocumension Therapeutics Company Information
- 6.5.2 Ocumension Therapeutics Business Overview
- 6.5.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Portfolio
- 6.5.5 Ocumension Therapeutics Recent Developments
- 6.6 Kubota Vision
- 6.6.1 Kubota Vision Company Information
- 6.6.2 Kubota Vision Business Overview
- 6.6.3 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Kubota Vision Dry Age-Related Macular Degeneration Product Portfolio
- 6.6.5 Kubota Vision Recent Developments
- 6.7 Iveric Bio
- 6.7.1 Iveric Bio Company Information
- 6.7.2 Iveric Bio Business Overview
- 6.7.3 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Iveric Bio Dry Age-Related Macular Degeneration Product Portfolio
- 6.7.5 Iveric Bio Recent Developments
- 6.8 Eyestem Research
- 6.8.1 Eyestem Research Company Information
- 6.8.2 Eyestem Research Business Overview
- 6.8.3 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Eyestem Research Dry Age-Related Macular Degeneration Product Portfolio
- 6.8.5 Eyestem Research Recent Developments
- 6.9 Belite Bio
- 6.9.1 Belite Bio Company Information
- 6.9.2 Belite Bio Business Overview
- 6.9.3 Belite Bio Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Belite Bio Dry Age-Related Macular Degeneration Product Portfolio
- 6.9.5 Belite Bio Recent Developments
- 6.10 Bausch Health
- 6.10.1 Bausch Health Company Information
- 6.10.2 Bausch Health Business Overview
- 6.10.3 Bausch Health Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Bausch Health Dry Age-Related Macular Degeneration Product Portfolio
- 6.10.5 Bausch Health Recent Developments
- 6.11 Allergan
- 6.11.1 Allergan Company Information
- 6.11.2 Allergan Business Overview
- 6.11.3 Allergan Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Allergan Dry Age-Related Macular Degeneration Product Portfolio
- 6.11.5 Allergan Recent Developments
- 6.12 Alimera Science
- 6.12.1 Alimera Science Company Information
- 6.12.2 Alimera Science Business Overview
- 6.12.3 Alimera Science Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Alimera Science Dry Age-Related Macular Degeneration Product Portfolio
- 6.12.5 Alimera Science Recent Developments
7 North America
- 7.1 North America Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Dry Age-Related Macular Degeneration Market Size by Country (2021-2026)
- 7.3 North America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Dry Age-Related Macular Degeneration Market Size by Country (2021-2026)
- 8.3 Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Dry Age-Related Macular Degeneration Market Size by Country (2021-2026)
- 10.3 South America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst